<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02782455</url>
  </required_header>
  <id_info>
    <org_study_id>DD</org_study_id>
    <nct_id>NCT02782455</nct_id>
  </id_info>
  <brief_title>Calcium Dobesilate vs Flavonoids for the Treatment of Early Hemorrhoidal Disease</brief_title>
  <official_title>Calcium Dobesilate vs Flavonoids for the Treatment of Early Hemorrhoidal Disease a Randomised Triple Blind Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Services Hospital, Lahore</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Services Hospital, Lahore</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Haemorrhoids are vascular cushions in the anal canal that help in the control of stool. When
      inflamed they become pathological and may present with protrusion and bleeding. A randomized,
      triple blind , controlled study will be conducted to compare the efficacy of calcium
      dobesilate against flavanoids in the management of early haemorrhoidal disease.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 2016</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency of occurrence of rectal bleeding after usage of drug</measure>
    <time_frame>1 weeks</time_frame>
    <description>After the patients will be given the two drugs they will be followed for the frequency of occurrence of rectal bleeding till two weeks</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>regression of hemorrhoids</measure>
    <time_frame>1 weeks</time_frame>
    <description>Patients will under gone per rectal examination and proctoscopy to look for grades of hemorrhoids whether its has decreased or increased.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Hemorrhoids</condition>
  <arm_group>
    <arm_group_label>CDobi</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Calcium dobesylate is given in this group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Flavono</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Flavonoids are given in this group</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Flavonoids</intervention_name>
    <description>Daflon is administered</description>
    <arm_group_label>Flavono</arm_group_label>
    <other_name>Daflon</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>CDobi</intervention_name>
    <description>Calcium dobesylate is administered</description>
    <arm_group_label>CDobi</arm_group_label>
    <other_name>dobesilate</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Grade I and Grade II hemorrhoids

        Exclusion Criteria:

          -  CLD

          -  colorectal/ anorectal Malignancy

          -  self medication

          -  local Quack Hakeem medication

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dr. Waris Farooka, MBBS, FCPS, FRCS, FACS</last_name>
    <role>Study Director</role>
    <affiliation>Services Institute of Medical Sciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Usman Ismat Butt, MBBS, FCPS</last_name>
    <phone>+92-342-4343806</phone>
    <email>usmanismatbutt@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sami Ullah, MBBS,BSc</last_name>
    <phone>+92-344-4000322</phone>
    <email>drsamiullahbhatti@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Services Hospital Lahore</name>
      <address>
        <city>Lahore</city>
        <state>Punjab</state>
        <zip>54000</zip>
        <country>Pakistan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sami Ullah, MBBS</last_name>
      <phone>+92-344-4000322</phone>
      <email>drsamiullahbhatti@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 10, 2016</study_first_submitted>
  <study_first_submitted_qc>May 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 25, 2016</study_first_posted>
  <last_update_submitted>January 26, 2017</last_update_submitted>
  <last_update_submitted_qc>January 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Services Hospital, Lahore</investigator_affiliation>
    <investigator_full_name>Dr. SamiUllah</investigator_full_name>
    <investigator_title>Postgraduate trainee</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhoids</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium, Dietary</mesh_term>
    <mesh_term>Calcium Dobesilate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

